Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs)

Volume 12, Issue 1, December 2023 .

Source: OncoImmunology - May 11, 2023 Category: Cancer & Oncology Authors: A Daban C Gonnin L Phan A Saldmann C Granier A Lillo-Lelouet C Le Beller J Pouchot l Weiss E Tartour E Fabre J Medioni S Oudard YA Vano MA Dragon-Durey A. Simonaggio Source Type: research